STOCK TITAN
  1. Home
  2. News
  3. EVH

Evolent Health Inc - EVH STOCK NEWS

Welcome to our dedicated news page for Evolent Health (Ticker: EVH), a resource for investors and traders seeking the latest updates and insights on Evolent Health.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Evolent Health's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Evolent Health's position in the market.

News
Evolent To Release First Quarter 2024 Financial Results on Thursday, May 9, 2024
Rhea-AI Summary
Evolent Health, Inc. (NYSE: EVH) will release its first quarter 2024 financial results on May 9, 2024, after market close, followed by a conference call. The company will participate in upcoming investor conferences including RBC Global Health Care Conference, Leerink Partners Healthcare Conference, and more.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.37%
Tags
earnings
-
News
Evolent Announces Fourth Quarter and Full Year 2023 Results
Rhea-AI Summary
Evolent Health, Inc. (NYSE: EVH) reported strong financial results for Q4 and FY 2023, with revenue increasing over 45%, net loss margin at (7.2)%, and adjusted EBITDA margin at 9.9%. The CEO highlighted successful integration of NIA and new revenue agreements for 2024, projecting revenue growth of 25% at the midpoint. Evolent's financial position is robust, with cash flow exceeding targets and improved balance sheet flexibility.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
14.44%
Tags
earnings
-
News
Evolent Adds Russell Glass, Headspace CEO, to Board of Directors
Rhea-AI Summary
Evolent Health, Inc. appoints Russell Glass to its Board of Directors, replacing Dr. Tunde Sotunde. Glass brings extensive experience in technology and health care. The company aims to continue its innovative leadership in the value-based specialty care market.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.33%
Tags
management
News
Evolent to Release Fourth Quarter 2023 Financial Results on Thursday, February 22, 2024
Rhea-AI Summary
Evolent Health, Inc. (EVH) will release its fourth quarter 2023 financial results on Thursday, Feb. 22, 2024, after market close. The company will also participate in upcoming investor conferences including Cowen 44th Annual Health Care Conference, Jefferies Annual Value-Based Healthcare Summit, Barclays 26th Annual Global Healthcare Conference, and Oppenheimer 34th Annual Healthcare MedTech & Services Conference.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.61%
Tags
earnings
-
News
Evolent Health, Inc. Announces Pricing of $350.0 Million of Convertible Senior Notes Due 2029 to Pay Down Senior Term Loan
Rhea-AI Summary
Evolent Health, Inc. (NYSE: EVH) announced the pricing of $350.0 million aggregate principal amount of 3.50% convertible senior notes due 2029. The notes are being offered to qualified institutional buyers and are convertible into cash, shares of Evolent's Class A common stock, or a combination of both. The initial conversion price represents a premium of approximately 42.50% over the closing price of the Class A common stock on December 5, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.15%
Tags
none
-
News
Evolent Health, Inc. Announces Proposed Offering of $350.0 Million of Convertible Senior Notes Due 2029 to Pay Down Senior Term Loan
Rhea-AI Summary
Evolent Health, Inc. (NYSE: EVH) plans to offer $350.0 million aggregate principal amount of convertible senior notes due 2029, with an option for additional $52.5 million aggregate principal amount of notes. The net proceeds will be used to prepay outstanding borrowings and pay related fees under its term loan facility, which matures in January 2029.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.1%
Tags
none
News
Evolent Announces Third Quarter 2023 Results
Rhea-AI Summary
Evolent Health, Inc. announced financial results for Q3 2023, with revenue of $511.0 million, a 44.9% increase compared to Q3 2022. The net loss attributable to common shareholders was $33.2 million, resulting in a net loss margin of (6.5)%. Evolent added three new operating partnerships and signed an important cross-sell agreement. The company raised the mid-point of its outlook for revenue and Adjusted EBITDA in 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
13.54%
Tags
earnings
-
News
Evolent to release third quarter financial results on Thursday, Nov. 2, 2023, and participate in upcoming investor conferences
Rhea-AI Summary
Evolent Health to release Q3 2023 financial results
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.64%
Tags
conferences earnings
-
News
Evolent saves Medicare more than $55 million through its Medicare Shared Savings Program ACO
Rhea-AI Summary
Evolent Health's ACO saved Medicare over $55 million in 2022, ranking in the top 2% of ACOs. The ACO improved quality and reduced costs by 5.6%. Evolent's Performance Suite partnership with Humana in North Florida to launch on September 1, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.76%
Tags
none
News
Evolent Health to Participate in Upcoming Conferences
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.39%
Tags
conferences
Stock EVH logo
Evolent Health Inc

NYSE:EVH

EVH Rankings

#1514 Ranked by Market Cap
#3583 Ranked by Stock Gains
N/A Ranked by Dividends

EVH Stock Data

3.43B
109.13M
4.17%
112.12%
9.31%
New Single-Family Housing Construction (except For-Sale Builders)
Construction
Link
US
Arlington

About EVH

our company evolent health supports progressive health care systems lead, build and own the path to value-based care. headquartered in arlington, virginia, we are backed by: the advisory board company (nasdaq: abco), university of pittsburgh medical center health plan, and tpg growth. we integrate the people, processes and technology needed to advance value-based care delivery and innovative payment models. our culture we’ve built a team of dedicated individuals who genuinely enjoy working together. our accessible leadership team cultivates an open-door environment. we take smart risks and when we fail, we fail forward. we respect and encourage commitments outside of work. while we don’t all work the same way or the same hours, we are all dedicated to exceptional results. our benefits treadmill desks, healthy snacks and wellness challenges are just part of our resolve to promote a healthy (and fun!) work environment. we recognize and reward our most valuable asset—our team—wi